| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 09/30/1999 | CA2325634A1 Smilagenin and anzurogenin-d for the treatment of alzheimer's disease |
| 09/29/1999 | EP0944598A2 Substituted benzamide derivatives and pharmaceutical compositions containing them |
| 09/29/1999 | EP0944584A1 Benzamidoaldehydes and their use as cysteine protease inhibitors |
| 09/28/1999 | US5959123 Reacating substituted amino acid with 3-amino-4-substituted-azetidine-2-one compound to form 3, 4-disubstituted-azetidine-2-one compound; useful for treating muscular dystrophy, arthritis, viral and parasitic infections |
| 09/28/1999 | US5958731 Cell junction PDZ protein |
| 09/24/1999 | CA2249660A1 Novel compounds |
| 09/23/1999 | WO1999047521A1 HYPNOTIC β-CARBOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICINAL PRODUCTS |
| 09/23/1999 | WO1999047508A1 Benzenesulfonamide-derivatives and their use as medicaments |
| 09/23/1999 | WO1999047490A1 Bicyclo[2.2.1]heptanes and related compounds |
| 09/23/1999 | WO1999032620A9 Insulin-like growth factor binding protein fragments and the utilization thereof |
| 09/23/1999 | CA2324270A1 Hypnotic .beta.-carboline derivatives, process for their preparation and their use as medicinal products |
| 09/23/1999 | CA2323783A1 Benzenesulfonamide-derivatives and their use as medicaments |
| 09/23/1999 | CA2322742A1 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 09/22/1999 | EP0943003A1 Insulin-like growth factor i (igf-i) expression system and methods of use |
| 09/22/1999 | EP0942960A1 Promotion of regeneration of organized tissues |
| 09/22/1999 | EP0942931A2 Modulation of interactions between myosin and integrins |
| 09/22/1999 | EP0942755A2 Treatment of diabetes with transcription factor gene |
| 09/22/1999 | EP0942723A1 4-aryl-3-hydroxyquinolin-2-one derivatives as ion channel modulators |
| 09/21/1999 | US5955338 Phosphatidylinositol 4,5-bisphosphate 5-phosphatase |
| 09/16/1999 | WO1999046248A1 1,2-diazepane derivatives as interleukin-1beta converting enzyme inhibitors |
| 09/16/1999 | WO1999046245A2 PROCESSES FOR THE PREPARATION OF (R)-α- (2,3-DIMETHOXYPHENYL)-1-[2-(4-FLUOROPHENYL)ETHYL]-4-PIPERIDINEMETHANOL |
| 09/16/1999 | WO1999045949A2 Use of follistatin to modulate gdf-8 and bmp-11 |
| 09/15/1999 | EP0941316A1 Human p2x purinoreceptor |
| 09/15/1999 | EP0941224A1 Multivalent salts of pyridostigmine and related compounds |
| 09/15/1999 | CN1228779A Spirocyclic metalloprotease inhibitors |
| 09/15/1999 | CN1228697A Method for in vivo reduction of iron levels and compositions useful therefor |
| 09/14/1999 | US5952319 Controlling male fertility in mammal |
| 09/10/1999 | WO1999045115A1 Human synapse related glycoproteins (hsrp) |
| 09/10/1999 | WO1999045108A2 Novel mechanically sensitive mammal potassium channel family activated by polyunsaturated fatty acids and their use particularly for screening medicines |
| 09/10/1999 | WO1999045024A1 Cholenic acid amides and pharmaceutical compositions thereof |
| 09/10/1999 | WO1999045006A1 Heterocyclic compounds as inhibitors of rotamase enzymes |
| 09/10/1999 | CA2322442A1 Heterocyclic compounds as inhibitors of rotamase enzymes |
| 09/10/1999 | CA2322381A1 Human synapse related glycoproteins (hsrp) |
| 09/08/1999 | CN1228091A Substituted 6,6-hetero-bicyclic derivatives |
| 09/07/1999 | US5948804 Anaesthetic premedication |
| 09/07/1999 | US5948767 Transport of active material into cells; drug delivery |
| 09/07/1999 | CA2098944C Novel pyrazole derivatives, method of preparing them and pharmaceutical compositions in which they are present |
| 09/02/1999 | WO1999043807A2 Human channel-related molecules |
| 09/02/1999 | WO1999043680A1 Substituted pyrrolobenzimidazoles for treating inflammatory diseases |
| 09/02/1999 | CA2321667A1 Human channel-related molecules |
| 09/02/1999 | CA2321559A1 Substituted pyrrolobenzimidazoles for treating inflammatory diseases |
| 09/01/1999 | EP0939127A2 Humanized immunoglobulins and their production and use |
| 09/01/1999 | EP0938477A1 Benzothiazo and related heterocyclic group-containing cysteine and serine protease inhibitors |
| 09/01/1999 | EP0938309A1 Methods for in vivo reduction of iron levels and compositions useful therefor |
| 09/01/1999 | EP0721348B1 Monoglyceride/lactate ester permeation enhancer |
| 09/01/1999 | CN1227554A Substituted 6,5-hetero-bicyclic derivatives |
| 08/31/1999 | US5945577 Nuclear transfer units for cells |
| 08/31/1999 | US5945302 Nucleotide sequences that code for proteins for use in recombinant technology, induce production of cytokines, activate cell differentiation, stimulate and suppress immune responses, and therapy for autoimmune diseases |
| 08/26/1999 | WO1999042573A1 Immunological methods to modulate myostatin in vertebrate subjects |
| 08/26/1999 | CA2687533A1 Immunological methods to modulate myostatin in vertebrate subjects |
| 08/25/1999 | EP0937041A1 Pure enantiomer basic aryl-cycloalkyl-hydroxycarboxylic acid esters, process for preparing the same and their use in medicaments |
| 08/25/1999 | EP0936912A1 Inhibitors of cysteine protease |
| 08/25/1999 | EP0936908A1 Anticonvulsant derivatives useful in treating amyotrophic lateral sclerosis (als) |
| 08/25/1999 | EP0936906A1 Reflux inhibitors |
| 08/24/1999 | US5942497 Purine compound and catecholamine compound containing compositions and methods for administration |
| 08/24/1999 | CA2176974C Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 08/18/1999 | EP0935465A1 Novel substituted imidazole compounds |
| 08/18/1999 | EP0935415A1 Methods for delivering compounds into a cell |
| 08/17/1999 | US5939100 Diminishing the desire of a subject to use tobacco by administering thepowdery pharmaceutical microspheres |
| 08/11/1999 | CN1225622A Substituted oxobutyric acids as matrix metalloprotease inhibitor |
| 08/11/1999 | CN1225620A Substituted 4-arylbutyric acid derivatives as matrix metalloprotease inhibitors |
| 08/10/1999 | US5935852 The present invention relates to a family of proteins designated as cerberus, which appears to be a pioneer protein, with a 9 cysteine residue pattern, which is present in the embryo. |
| 08/10/1999 | US5935602 Dosage forms of risedronate |
| 08/05/1999 | WO1999038532A2 Methods for the prevention and treatment of fibrosis and sclerosis |
| 08/05/1999 | WO1999038516A1 Neurotrophic properties of ipgs and ipg analogues |
| 08/05/1999 | WO1999038503A1 Pharmacological uses of optically pure (+)-bupropion |
| 08/05/1999 | WO1999023092A3 3-aminoalkylamino-2h-1,4-benzoxa(thia-)zines and pharmaceutical compositions containing them |
| 08/05/1999 | CA2318921A1 Pharmacological uses of optically pure (+)-bupropion |
| 08/05/1999 | CA2318584A1 Neurotrophic properties of ipgs and ipg analogues |
| 08/05/1999 | CA2318336A1 Methods for the prevention and treatment of fibrosis and sclerosis |
| 08/04/1999 | CN1225087A Process for preparing 1-substituted 4-cyano-1,2,3-triazoles |
| 08/04/1999 | CN1225085A Substituted pyridines as selective cyclooxygenase-2 inhibitors |
| 08/03/1999 | US5932598 Prodrugs of benzenesulfonamide-containing COX-2 inhibitors |
| 08/03/1999 | CA2171561C K-252a derivatives which enhance neurotrophin-induced activity |
| 07/30/1999 | CA2246001A1 Novel compounds |
| 07/29/1999 | WO1999037612A1 Azetidinecarboxamide derivatives for treating cns disorders |
| 07/29/1999 | WO1999037326A1 Biologically active hemagglutinin from type a clostridium botulinum and methods of use |
| 07/29/1999 | WO1999037314A1 Sea cucumber carotenoid lipid fraction products and methods of use |
| 07/29/1999 | WO1999037301A1 New use for pain management |
| 07/29/1999 | CA2319113A1 Biologically active hemagglutinin from type a clostridium botulinum and methods of use |
| 07/28/1999 | EP0931148A1 Fibroblast growth factor homologs |
| 07/28/1999 | CN1223877A Medicinal liquor for treatment of atrophic debility of bone and eliminating wind |
| 07/28/1999 | CN1044367C (S)-alpha-phenyl-2-pyridine-ethylamine, its preparing method and composition contg. same |
| 07/27/1999 | US5929084 Treating myasthenia by inhibiting cholinesterase comprising administering huperazine a derivative to the patient |
| 07/27/1999 | CA2170700C Pyrazolopyrimidines and pyrrolopyrimidines for treatment of neuronal and other disorders |
| 07/22/1999 | WO1999025814B1 Genetically-modified myogenic progenitors and their use in cell and gene therapy |
| 07/21/1999 | EP0929571A1 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators |
| 07/21/1999 | EP0759025B1 Amide derivatives and their therapeutic use |
| 07/20/1999 | US5925351 Soluble lymphotoxin-β receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease |
| 07/15/1999 | WO1999034827A1 Activated t-cells and their uses |
| 07/15/1999 | WO1999034784A2 Pharmaceutical compositions comprising disulfiram for inhibiting angiogenesis |
| 07/13/1999 | US5922761 Methods for in vivo reduction of iron levels and compositions useful therefor |
| 07/13/1999 | US5922735 4-aryl-3-hydroxyquinolin-2-one derivatives as ion channel modulators |
| 07/13/1999 | US5922571 Polynucleotides encoding a protein kinase C homolog |
| 07/13/1999 | US5922318 Drug protein |
| 07/08/1999 | WO1999033836A1 3'-epimeric k-252a derivatives |
| 07/08/1999 | WO1999033834A1 Novel farnesyl transferase inhibitors, preparation, pharmaceutical compositions containing them and use for preparing medicines |
| 07/08/1999 | WO1999033799A1 Gamma-glutamyl and beta-aspartyl containing immunomodulator compounds and methods therewith |
| 07/08/1999 | WO1999011275A9 Use of immunostimulatory oligonucleotides for preventing or reducing antigen-stimulated, granulocyte-mediated inflammation |
| 07/08/1999 | CA2315144A1 Novel farnesyl transferase inhibitors, preparation, pharmaceutical compositions containing them and use for preparing medicines |